Showing results (201-210 of 232) with videos related to

Sort By:
Pageof 24
Journal of Clinical and Translational Hepatology|February 9, 2026
Expert Consensus on the Diagnosis and Management of Inherited Hyperbilirubinemia (2025)Sujun Zheng, Xiaoyuan Xu, Yuemin Nan, et al.
Scandinavian Journal of Public Health|May 3, 2018
China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis BShan Shan, Wei Wei, Yuanyuan Kong, et al.
Frontiers in Physiology|November 30, 2016
Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal ModelsDanmei Su, Yuanyang Nie, Airu Zhu, et al.
Antiviral Research|August 19, 2018
HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland ChinaLai Wei, Masao Omata, Young-Suk Lim, et al.
Cell & Bioscience|December 22, 2023
Precision nephrotoxicity testing using 3D in vitro modelsPengfei Yu, Hainan Zhu, Carol Christine Bosholm, et al.
Frontiers in Nutrition|January 2, 2023
Age-specific reference values for low psoas muscle index at the L3 vertebra level in healthy populations: A multicenter studyMing Kong, Ning Lin, Lili Wang, et al.
Frontiers in Nutrition|February 10, 2023
Corrigendum: Age-specific reference values for low psoas muscle index at the L3 vertebra level in healthy populations: A multicenter studyMing Kong, Ning Lin, Lili Wang, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 9, 2022
Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre studyMing Kong, Nan Geng, Ying Zhou, et al.
Frontiers in Nutrition|May 13, 2022
Assessing Visceral Obesity and Abdominal Adipose Tissue Distribution in Healthy Populations Based on Computed Tomography: A Large Multicenter Cross-Sectional StudyMing Kong, Manman Xu, Ying Zhou, et al.
Journal of Clinical and Translational Hepatology|July 5, 2021
3-year Treatment of Tenofovir Alafenamide <i>vs</i>. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in ChinaJinlin Hou, Qin Ning, Zhongping Duan, et al.
Pageof 24